ABVC BIOPHARMA, INC. Quarterly Deferred Tax Assets, Gross in USD from Q3 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Abvc Biopharma, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q3 2011 to Q3 2024.
  • Abvc Biopharma, Inc. Deferred Tax Assets, Gross for the quarter ending September 30, 2024 was $6.27M.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.27M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $6.24M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $6.25M Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $6.28M -$295K -4.49% Dec 31, 2023 10-Q 2024-11-14
Q4 2022 $6.58M +$5.59M +570% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.01M Sep 30, 2022 10-Q 2022-11-14
Q4 2021 $982K Dec 31, 2021 10-Q 2022-11-14
Q4 2015 $25.7K +$22K +585% Dec 31, 2015 10-Q 2016-02-23
Q3 2015 $29.1K +$25.6K +734% Sep 30, 2015 10-K 2015-11-27
Q2 2015 $8.38K Jun 30, 2015 10-Q 2015-08-19
Q1 2015 $3.89K Mar 31, 2015 10-Q/A 2015-06-05
Q4 2014 $3.76K +$3.76K Dec 31, 2014 10-Q 2016-02-23
Q3 2014 $3.49K +$3.49K Sep 30, 2014 10-K 2015-11-27
Q4 2013 $0 Dec 31, 2013 10-Q 2015-04-17
Q3 2013 $0 -$1.94M -100% Sep 30, 2013 10-K 2015-04-17
Q3 2012 $1.94M -$2.68M -58.1% Sep 30, 2012 10-K 2015-04-16
Q3 2011 $4.62M Sep 30, 2011 10-K 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.